Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Evolus, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 172 | 160 | −12 |
| Shares | 58.5M | 54.5M | −4.04M (−6.9%) |
| Value | $538.8M | $334.4M | −$204.3M (−37.9%) |
New holders (24)
Institutions that held Evolus, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (36)
Institutions that held Evolus, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.